These final results, along with a preceding report demonstrating that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like actions in mice,2 support the idea of focusing on ACKR3 as a novel way to modulate the opioid program, which could open up new therapeutic avenues for opioid-similar Ailments. The nutritional supplement https://evansu455ylb4.blogcudinti.com/profile